NEW YORK (GenomeWeb) – Rainbow Genomics said today that it is partnering with Color to provide hereditary cancer and heart health genetic risk assessment tests in Hong Kong.

Rainbow, a preferred partner of Color in Hong Kong, will offer that firm's genetic tests for the analysis of a patient's risk for eight hereditary cancers and four hereditary heart health conditions. The partnership, Rainbow said, will provide a fully integrated solution for actionable clinical test results at an affordable price point, though it did not elaborate.